Questionnaires in Assessing Attitudes About Legalization of Marijuana Use in Participants With Cancer

NCT03360799 | Completed

• 3 other identifiers: 2017-0568NCI-2018-01026P30CA016672
• Study Type: observational
• Target: 103
• Locations: 1 country
• Sites: 2

Brief Summary

This trial studies attitudes about legalization of marijuana use in participants with cancer. Questionnaires may help doctors to learn about and compare the attitudes that patients in non-legalized and legalized states have towards the legalization of medical marijuana.

Conditions

Malignant Neoplasm

Outcome Measures

Primary Outcomes (1)

• Positive attitude regarding the legalization of medical marijuana for medical purposes

  Will be defined as answering "Completely Agree" or "Slightly Agree" to the question 1 in Marijuana Survey for Patients. The number of subjects with positive attitude towards legalizing medical marijuana will be compared between patients from Texas and Arizona States using one-sided Fisher's exact test or chi-squared test, whichever appropriate. A logistic model will be used to assess the effect of state of residency, adjusting for other covariates such as gender, age, race, etc. Will employ inverse probability of state weighting using the propensity score on all patients to estimate the difference in attitudes of marijuana use between the states. In the weighted sample, will also compute the standardized differences to evaluate the balance of baseline covariates between the two states. The propensity score model may be adjusted to further minimize some of the residual difference in the distribution of the baseline covariates between the two states.

  Up to 1 year

Secondary Outcomes (2)

• Participants' belief in the usefulness of medical marijuana between those who are residents of Texas versus Arizona

  Up to 1 year

• Perception of medical marijuana

  Up to 1 year

Study Arms (1)

Observational (questionnaire)

Participants complete 5 questionnaires.

Other: Questionnaire Administration

Interventions

Questionnaire Administration OTHER

Complete questionnaires

Observational (questionnaire)

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Participants with cancer seen by the Palliative Care team at Banner MD Anderson or University of Texas (UT) MD Anderson

You may qualify if:

• Patients (inpatient or outpatient) seen by the Palliative Care team at Banner MD Anderson or UT MD Anderson
• Patients able to speak and read English
• Patients enrolled in each site must be a resident of the state where that site is located (e.g. if a patient is enrolled at UT MD Anderson Cancer Center \[MDACC\], they should be resident of the state of Texas)
• Patients should have a cancer diagnosis

You may not qualify if:

• Patients who are not able to speak or read English
• Altered mental status as determined by the interviewer based on the ability to understand the nature of the study and consent process

Sponsors & Collaborators

• M.D. Anderson Cancer Center: lead
• National Cancer Institute (NCI): collaborator

Study Sites (2)

Banner MD Anderson Cancer Center

Gilbert, Arizona, 85234, United States

Location

M D Anderson Cancer Center

Houston, Texas, 77030, United States

Location

Related Links

• University of Texas MD Anderson Cancer Center Website

MeSH Terms

Conditions

Neoplasms

Study Officials

• Kimberson C Tanco

  M.D. Anderson Cancer Center

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: November 28, 2017
• First Posted: December 4, 2017
• Study Start: November 17, 2017
• Primary Completion: August 26, 2019
• Study Completion: August 26, 2019
• Last Updated: August 30, 2019

Record last verified: 2019-08

Locations

US (2)